Abstract
BackgroundAdrenocortical carcinoma (ACC) is a rare and highly aggressive endocrine malignancy, of which >40% present with glucocorticoid excess. Glucocorticoids and glucocorticoid receptor (GR) signaling have long been thought to suppress...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have